KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CLVS
Delisted

Clovis Oncology Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.151 $0.151 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $0.120 $0.168
52 weeks $0.0471 $3.25

Historical Clovis Oncology prices

Date Open High Low Close Volume
Apr 19, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 18, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 17, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 14, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 13, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 12, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 11, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 10, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 06, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 05, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 04, 2023 $0.151 $0.151 $0.151 $0.151 0
Apr 03, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 31, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 30, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 29, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 28, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 27, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 24, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 23, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 22, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 21, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 20, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 17, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 16, 2023 $0.151 $0.151 $0.151 $0.151 0
Mar 15, 2023 $0.151 $0.151 $0.151 $0.151 0
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT